Evaluation of stannous oxidation in the preparation of ultrahigh-purity 99mtc(v)-dmsa

Nuclear Medicine Communications

Volumn 22, Issue 11, 2001, Pages 1261-1266

  Kumar, V ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Radiochemical purity; Renal imaging; Stannous oxidation; Technetium 99m dimercaptosuccinic acid

Indexed keywords

PHYTATE TECHNETIUM TIN TC 99M; SUCCIMER TC 99M;

ARTICLE; BONE METASTASIS; BRAIN TUMOR; CANCER PATIENT; CHROMATOGRAPHY; DIAGNOSTIC IMAGING; DRUG UPTAKE; HUMAN; KIDNEY CORTEX; OXYGENATION; PROSTATE CANCER; RADIOCHEMISTRY; THIN LAYER CHROMATOGRAPHY;

DRUG STABILITY; HUMANS; KINETICS; NEOPLASMS; OXIDATION-REDUCTION; RADIOPHARMACEUTICALS; REAGENT KITS, DIAGNOSTIC; SODIUM BICARBONATE; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID; TISSUE DISTRIBUTION;

EID: 0034759781     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200111000-00015     Document Type: Review

References (13)

1. Hirano T, Otake H, Shibasaki T, Tamura M, Endo K. Differentiating histologic malignancy of primary brain tumours: pentavalent technetium-99m DMSA. J Nucl Med 1997; 38: 20-26.
2. 99mTc)-MDP: an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. J Nucl Med 1988; 29: 33-38.
3. Chauhan UPS, Babbar A, Kashyap R, Prakash R. Evaluation of a DMSA kit for instant preparation of 99mTc(V)-DMSA for tumour and metastasis scintigraphy. Nucl Med Biol 1992; 19: 825-830.
4. Lam ASK, Puncher MRB, Blower PJ. in vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid. Eur J Nucl Med 1996; 23: 1575-1582.
5. Blower PJ, Singh J, Clarke SEM. The chemical identity of pentavalent technetium-99m dimercaptosuccinic acid. J Nucl Med 1991; 32: 845-849.
6. Ohta H, Yamamoto K, Endo K, et al. A new imaging agent for medullary carcinoma of the thyroid. J Nucl Med 1984; 25: 323-325.
7. 99mTc(III)-DMSA. Nucl Med Biol 1995; 22: 689-691.
8. Kobayashi H, Suzuki KH, Sakahara H, et al. Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid. Eur J Nucl Med 1995; 22: 559-562.
9. 99mTc-pentavalent DMSA. Eur J Nucl Med 2000; 27: 1219.
10. 99mTc(V)-DMSA]. J Appl Radiat Isot 1985; 36: 311-312.
11. 99mTc labelled pentavalent DMSA and its evaluation as a tumour imaging agent. J Nucl Med Biol 1991; 35: 100-104.
12. 99mTc(V)DMSA. Nucl Med Commun 1987; 8: 184-185.
13. 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone. Eur J Nucl Med 2000; 27: 1405-1409.